[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.127.188. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 3,738
Citations 0
Editorial
August 16, 2016

Osteoporosis Therapy in Postmenopausal Women With High Risk of Fracture

Author Affiliations
  • 1Division of Endocrinology, Diabetes, and Metabolism, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
  • 2Endocrine Research Unit, San Francisco Department of Veterans Affairs Medical Center, University of California, San Francisco
  • 3Associate Editor, JAMA
JAMA. 2016;316(7):715-716. doi:10.1001/jama.2016.11032

Forty-six percent of white women 50 years of age and older will sustain an osteoporotic fracture during their remaining lifetime.1 Vertebral fractures are the most common osteoporotic fracture; two-thirds are asymptomatic, presenting as incidental findings on radiographs.2 After an initial hip or vertebral fracture, risk of a second fracture more than doubles, with highest risk in the first year.3 Fall prevention, weight-bearing exercise, and adequate intake of calcium and vitamin D are cornerstones of fracture prevention.4 However, medical therapy is often required to treat osteoporosis. Patients who have already sustained a fragility fracture of the hip or spine should be considered for medical therapy to prevent additional fractures, even without bone mineral density (BMD) testing.4

First Page Preview View Large
First page PDF preview
First page PDF preview
×